2[1]Thomax X, Archimbaud E, Charrin C, et al. CD34 expoession is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Lewkemia, 1995; 9:249. 被引量：1
3[2]Catovsky D, Matutes E, Buccheri V, et al. A class ification of acute leukemia for the 1990s. Ann Hematol, 1991; 62:16. 被引量：1
4[3]Urbano-lspizua A, Matutes E, Villamor N, et al. Clinical significance of the presence of myeloid associated antigen in acute lymphoblastic leukemia. Br j Haematol, 1990;75:202. 被引量：1
5[4]preti HA, Huh Yo, Brien O, et al. Myeloid markers in adult acute lymphoblastic leukemia. Cancer, 1995;76:1564. 被引量：1
6[5]Childs CC. Hirsch-Ginsberg C, walters RS, et al. Myeloid sur face antigen positive acute lymphoblastic leukemia: immunophenotypic, ulerastructural, cytogenetic and mdecular characteristics. Leukemia, 1989;3:777. 被引量：1
7[6]Specehia G, Debcllis G, Mestice A, et al. Myeloid markers in adult lymphoblastic leukemia. Br J Hematol, 1996;93(suppl): 61. 被引量：1
8Khalidi HS, Chang KL, Medeiros LJ, et al. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases[ J]. Am J Clin Pathol, 1999,111 (4) :467-476. 被引量：1
9Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL) [ J ]. Leukemia, 1995,9(10) :1783-1786. 被引量：1
10Kita K, Miwa H, Nakase K, et al. Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma[ J]. Blood, 1993,81 (9) :2399-2405. 被引量：1
